Skip to content

Evaluation of Socio-professional Inclusion for Young Adults Aged 15-25 Living With a Rare Genetic Disability

Evaluation of Socio-professional Inclusion for Young Adults Aged 15-25 Living With a Rare Genetic Disability

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07527624
Acronym
ImagineLaSuite
Enrollment
300
Registered
2026-04-14
Start date
2024-01-08
Completion date
2026-08-08
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rare Diseases

Brief summary

Rare diseases are often synonymous with difficulties for sufferers, whether physical, mental or social. Patients suffering from rare diseases face specific problems, such as the long wait for a diagnosis, the geographical distance between the rare disease reference center and home, and the isolation created by this very disabling disease... Children suffering from rare genetic diseases have difficulty accessing higher education, but above all in finding an internship or work-study placement, due to the rarity of their disability. The aim of this study, entitled "Imagine La Suite", is to assess the difficulties encountered by young people with rare genetic diseases and disabilities in their search for vocational and university training or employment.

Interventions

OTHERsurvey

Patients take part in a survey, completing a form in less than 30 minutes

Sponsors

Imagine Institute
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 25 Years

Inclusion criteria

* Current age 15-25 years born between 1997 and 2007 * Rare genetic disease confirmed by a genetic test, originating in childhood and followed at Necker in the networks of the following disease reference centers: * epilepsy without deficiency ; * genodermatosis ; * constitutional bone diseases ; * craniofacial malformations; * deafness;

Exclusion criteria

* Patient or parent's opposition to study participation * Patient with intellectual disability (IQ \< 70) * Patients with pathologies involving intellectual disability and patients with a clinical sign of intellectual disability.

Design outcomes

Primary

MeasureTime frame
Entry into a training program, validation of a diploma, obtaining a 1st stable job18 Months

Secondary

MeasureTime frame
Characterize the pathology components of the care pathway, barriers/ strengths to inclusion18 Months
Use of tools to facilitate socio-professional inclusion18 Months
Number of HR company representatives made aware of rare diseases18 Months

Countries

France

Contacts

CONTACTFatima clinical project manager, Medical doctor
recherche-clinique@institutimagine.org+33 (0)1 42 75 45 65

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026